BioCentury
ARTICLE | Company News

Bio-Matrix Scientific gene/cell therapy, hematology, cancer news

March 17, 2014 7:00 AM UTC

Bio-Matrix said that all shareholders on record as of March 18 will receive one share in subsidiary Regen BioPharma Inc. for every 147 Bio-Matrix shares held. Bio-Matrix plans to distribute 20 million...